Xtant Medical Short Term Debt Over Time
| XTNT Stock | USD 0.47 0.01 3.04% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Xtant Medical Performance and Xtant Medical Correlation. Xtant |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xtant Medical. If investors know Xtant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xtant Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share | Quarterly Revenue Growth 0.117 | Return On Assets | Return On Equity |
The market value of Xtant Medical Holdings is measured differently than its book value, which is the value of Xtant that is recorded on the company's balance sheet. Investors also form their own opinion of Xtant Medical's value that differs from its market value or its book value, called intrinsic value, which is Xtant Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xtant Medical's market value can be influenced by many factors that don't directly affect Xtant Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xtant Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xtant Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xtant Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Short Term Debt Analysis
Compare Xtant Medical Holdings and related stocks such as Neuropace, Electromed, and Orthopediatrics Corp Short Term Debt Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPCE | 62.8 M | 62.8 M | 62.8 M | 62.8 M | 62.8 M | 62.8 M | 62.8 M | 62.8 M | 62.8 M | 62.8 M | 2 M | 2.8 M | 2.8 M | 1.6 M | 1.9 M | 1.8 M |
| ELMD | 371 K | 2 M | 57.5 K | 46.4 K | 48.7 K | 46.3 K | 50.7 K | 1.1 M | 30.3 K | 72.3 K | 33 K | 80 K | 80 K | 80 K | 72 K | 68.4 K |
| KIDS | 97 K | 97 K | 97 K | 97 K | 97 K | 101 K | 107 K | 113 K | 118 K | 124 K | 131 K | 137 K | 144 K | 152 K | 174.8 K | 134.6 K |
| SRDX | 4.8 M | 1.7 M | 997 K | 1.1 M | 829 K | 7.4 M | 5.6 M | 2.5 M | 2.1 M | 436 K | 10.5 M | 11 M | 872 K | 1 M | 936 K | 889.2 K |
| FNA | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 2.2 M | 153 K | 1.2 M | 1.2 M | 1.1 M | 1 M |
| LIVN | 100 K | 4 K | 176 M | 176 M | 176 M | 82.5 M | 47.7 M | 84 M | 28.8 M | 77.4 M | 24.6 M | 240.9 M | 32.8 M | 26.5 M | 87 M | 60.7 M |
| ANIK | 1000 K | 1.6 M | 1.6 M | 66 K | 66 K | 66 K | 48 K | 1.1 M | 1.1 M | 1.1 M | 1.6 M | 1.7 M | 2.1 M | 2.1 M | 2.5 M | 1.6 M |
| AIMD | 5.8 K | 88.5 K | 2.8 M | 3.5 M | 234.6 K | 384.6 K | 791.5 K | 886.5 K | 513.4 K | 444.6 K | 953 K | 3.6 M | 1.3 M | 42 K | 37.8 K | 35.9 K |
| TNON | 734.4 K | 734.4 K | 734.4 K | 734.4 K | 734.4 K | 734.4 K | 734.4 K | 734.4 K | 734.4 K | 734.4 K | 241.4 K | 13.7 M | 456 K | 1.4 M | 1.6 M | 1.6 M |
| SSKN | 228.6 K | 956.5 K | 956.5 K | 844 K | 842 K | 299 K | 2.1 M | 2.7 M | 252 K | 252 K | 9.1 M | 636 K | 710 K | 352 K | 316.8 K | 301 K |
| MOVE | 248 K | 248 K | 248 K | 248 K | 248 K | 248 K | 248 K | 248 K | 248 K | 248 K | 248 K | 212 K | 212 K | 217 K | 195.3 K | 180.5 K |
| CVRX | 222 K | 222 K | 222 K | 222 K | 222 K | 222 K | 222 K | 222 K | 222 K | 222 K | 222 K | 222 K | 222 K | 231 K | 265.6 K | 249.2 K |
| OFIX | 2.2 M | 18.8 M | 16 K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 323 K | 2.6 M | 4.4 M | 2.3 M | 5.4 M | 4.8 M | 4.8 M |
| AORT | 1.1 M | 13.1 M | 14 M | 14.1 M | 4.6 M | 4.6 M | 4.6 M | 1.3 M | 1.9 M | 7.2 M | 13.9 M | 9 M | 9.2 M | 5.4 M | 5.3 M | 6.8 M |
Xtant Medical Holdings and related stocks such as Neuropace, Electromed, and Orthopediatrics Corp Short Term Debt description
My Equities
My Current Equities and Potential Positions
| Xtant Medical Holdings | XTNT |
| Classification | Drugs |
| Location | Montana; U.S.A |
| Exchange | NYSE MKT Exchange |
USD 0.44
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.